ASH 2019: High-Dose Cyclophosphamide Reduces Graft-Versus-Host Disease Following Stem Cell Transplantation
This more intensified immunosuppression might serve as superior prophylaxis in the setting of reduced intensity conditioning
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.